LLY

1,022.7

+0.26%↑

JNJ

246.77

+0.74%↑

ABBV

224.2

-1.89%↓

NVS

163.46

-1.15%↓

MRK

121.78

+0.14%↑

LLY

1,022.7

+0.26%↑

JNJ

246.77

+0.74%↑

ABBV

224.2

-1.89%↓

NVS

163.46

-1.15%↓

MRK

121.78

+0.14%↑

LLY

1,022.7

+0.26%↑

JNJ

246.77

+0.74%↑

ABBV

224.2

-1.89%↓

NVS

163.46

-1.15%↓

MRK

121.78

+0.14%↑

LLY

1,022.7

+0.26%↑

JNJ

246.77

+0.74%↑

ABBV

224.2

-1.89%↓

NVS

163.46

-1.15%↓

MRK

121.78

+0.14%↑

LLY

1,022.7

+0.26%↑

JNJ

246.77

+0.74%↑

ABBV

224.2

-1.89%↓

NVS

163.46

-1.15%↓

MRK

121.78

+0.14%↑

Search

DaVita Inc

Cerrado

SectorSalud

147.25 -0.23

Resumen

Variación precio

24h

Actual

Mínimo

146.09

Máximo

148.67

Métricas clave

By Trading Economics

Ingresos

769M

1.1B

Ventas

200M

3.6B

P/B

Media del Sector

15.679

110.024

BPA

3.4

Margen de beneficio

29.801

Empleados

78,000

EBITDA

81M

718M

Recomendaciones

By TipRanks

Recomendaciones

Neutral

Estimación a 12 meses

+9.1% upside

Dividendos

By Dow Jones

Próximas Ganancias

11 may 2026

Estadísticas de Mercado

By TradingEconomics

Capitalización de Mercado

2B

10B

Apertura anterior

147.48

Cierre anterior

147.25

Puntuación técnica

By Trading Central

Confianza

Strong Bullish Evidence

DaVita Inc Gráfico

El rendimiento pasado no es un indicador fiable de resultados futuros.

Noticias Relacionadas

29 dic 2025, 06:30 UTC

Adquisiciones, fusiones, absorciones

Berkshire's Buffett Is Stepping Down. Why Little Will Change and Why That's OK. -- Barrons.com

21 mar 2025, 08:19 UTC

Charlas de Mercado

Fresenius Medical Care's Revenue Estimates Lowered by Jefferies on U.S. Volume Concerns -- Market Talk

Comparación entre iguales

Cambio de precio

DaVita Inc Esperado

Precio Objetivo

By TipRanks

9.1% repunte

Estimación a 12 meses

Media 162.5 USD  9.1%

Máximo 190 USD

Mínimo 144 USD

De acuerdo con 5 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para DaVita Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Neutral

5 ratings

1

Comprar

3

Mantener

1

Vender

Puntuación técnica

By Trading Central

142.36 / 144.275Soporte y Resistencia

Corto Plazo

Strong Bullish Evidence

Medio plazo

Bearish Evidence

Largo Plazo

Bearish Evidence

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de DaVita Inc

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engages in the provision of acute inpatient dialysis services and related laboratory services; and transplant software business. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.
help-icon Live chat